TG Therapeutics data shows BRIUMVI reduces relapse rates in active MS patients
Go back to TG Therapeutics data shows BRIUMVI reduces relapse rates in active MS patients| TG THERAP (NASDAQ: TGTX) | Delayed: 53.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.52 | 52 Week High | $14.87 | |||
| Open | $53.52 | 52 Week Low | $4.90 | |||
| Day High | $53.52 | P/E | N/A | |||
| Day Low | $53.52 | EPS | $-0.67 | |||
| Volume | 128 | |||||

